Renalytix Plc (RNLXY)
OTCMKTS · Delayed Price · Currency is USD
0.2730
+0.0130 (5.00%)
Oct 17, 2025, 4:00 PM EDT
Renalytix Market Cap
Renalytix has a market cap or net worth of $42.18 million as of October 17, 2025. Its market cap has increased by 142.87% in one year.
Market Cap
42.18M
Enterprise Value
40.66M
Revenue
2.89M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.27
Market Cap Chart
Since November 6, 2018, Renalytix's market cap has decreased from 84.47M to 42.18M, a decrease of -50.07%. That is a compound annual growth rate of -9.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 42.18M | -5.37% |
| Dec 31, 2024 | 44.57M | 125.93% |
| Dec 29, 2023 | 19.73M | -69.84% |
| Dec 30, 2022 | 65.42M | -89.22% |
| Dec 31, 2021 | 607.05M | 26.62% |
| Dec 31, 2020 | 479.42M | 67.37% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 6, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glass House Brands | 671.98M |
| Elite Pharmaceuticals | 660.06M |
| Veradigm | 517.28M |
| Northwest Biotherapeutics | 347.69M |
| CytoDyn | 336.10M |
| Nika Pharmaceuticals | 333.67M |
| Silence Therapeutics | 307.02M |
| American Oncology Network | 277.57M |